Associations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes

被引:19
作者
Bajor, Laura A. [1 ,2 ]
Gunzler, Douglas [3 ]
Einstadter, Douglas [3 ]
Thomas, Charles [3 ]
McCormick, Richard [3 ]
Perzynski, Adam T. [3 ]
Kanuch, Stephanie W. [3 ]
Cassidy, Kristin A. [4 ]
Dawson, Neal V. [3 ]
Sajatovic, Martha [5 ]
机构
[1] VA Boston Healthcare Ctr, Boston, MA USA
[2] Harvard Univ, Sch Med, Jamaica Plain, MA 02130 USA
[3] Case Western Reserve Univ, MetroHlth Med Ctr, Ctr Hlth Care Res & Policy, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Sch Med, Cleveland, OH 44106 USA
[5] Univ Hosp Case Med Ctr, Neurol & Behav Outcomes Ctr, Cleveland, OH USA
关键词
Serious mental illness; schizophrenia; bipolar disorder; anxiety; diabetes mellitus; comorbidity; ATYPICAL ANTIPSYCHOTIC USE; SCHIZOPHRENIA SPECTRUM DISORDERS; BIPOLAR DISORDER; DSM-IV; PERIPHERAL NEUROPATHY; INCREASED PREVALENCE; DEPRESSION; RISK; MELLITUS; MORTALITY;
D O I
10.1177/0091217415589307
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective While previous work has demonstrated elevation of both comorbid anxiety disorders and diabetes mellitus type II in individuals with serious mental illness, little is known regarding the impact of comorbid anxiety on diabetes mellitus type II outcomes in serious mental illness populations. We analyzed baseline data from patients with serious mental illness and diabetes mellitus type II to examine relationships between comorbid anxiety, glucose control as measured by hemoglobin A1c score, and overall illness burden. Methods Using baseline data from an ongoing prospective treatment study involving 157 individuals with serious mental illness and diabetes mellitus type II, we compared individuals with and without a comorbid anxiety disorder and compared hemoglobin A1c levels between these groups to assess the relationship between anxiety and management of diabetes mellitus type II. We conducted a similar analysis using cumulative number of anxiety diagnoses as a proxy for anxiety load. Finally, we searched for associations between anxiety and overall medical illness burden as measured by Charlson score. Results Anxiety disorders were seen in 33.1% (N=52) of individuals with serious mental illness and diabetes mellitus type II and were associated with increased severity of depressive symptoms and decreased function. Hemoglobin A1c levels were not significantly different in those with or without anxiety, and having multiple anxiety disorders was not associated with differences in diabetes mellitus type II control. However, depressive symptoms were significantly associated with higher hemoglobin A1c levels. Neither comorbid anxiety nor anxiety load was significantly associated with overall medical burden. Conclusion One in three people with serious mental illness and diabetes mellitus type II had anxiety. Depressive symptoms were significantly associated with Hb1Ac levels while anxiety symptoms had no relation to hemoglobin A1c; this is consistent with previously published work. More studies are needed to better understand the relationship between depression, anxiety, and health management in people with serious mental illness and diabetes mellitus type II.
引用
收藏
页码:309 / 320
页数:12
相关论文
共 54 条
[1]   How Prevalent Are Anxiety Disorders in Schizophrenia? A Meta-Analysis and Critical Review on a Significant Association [J].
Achim, Amelie M. ;
Maziade, Michel ;
Raymond, Eric ;
Olivier, David ;
Merette, Chantal ;
Roy, Marc-Andre .
SCHIZOPHRENIA BULLETIN, 2011, 37 (04) :811-821
[2]  
Balhara Yatan Pal Singh, 2011, Indian J Endocrinol Metab, V15, pS50, DOI 10.4103/2230-8210.83057
[3]  
Blixen C., 2011, CUTTING EDGE PSYCHIA, V1, P106
[4]   Training peer educators to promote self-management skills in people with serious mental illness (SMI) and diabetes (DM) in a primary health care setting [J].
Blixen, Carol ;
Perzynski, Adam ;
Kanuch, Stephanie ;
Dawson, Neal ;
Kaiser, Denise ;
Lawless, Mary E. ;
Seeholzer, Eileen ;
Sajatovic, Martha .
PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2015, 16 (02) :127-137
[5]  
Boschert S, 2005, CLIN PSYCHIAT NEWS, P21
[6]  
Boschert S, 2008, USE CNS MED MAY RED, P39
[7]   Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life [J].
Braga, RJ ;
Mendlowicz, MV ;
Marrocos, RP ;
Figueira, IL .
JOURNAL OF PSYCHIATRIC RESEARCH, 2005, 39 (04) :409-414
[8]   Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort [J].
Brown, Steve ;
Mitchell, Clemence .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2012, 47 (06) :843-847
[9]   Twenty-five year mortality of a community cohort with schizophrenia [J].
Brown, Steve ;
Kim, Miranda ;
Mitchell, Clemence ;
Inskip, Hazel .
BRITISH JOURNAL OF PSYCHIATRY, 2010, 196 (02) :116-121
[10]   Psychiatric Comorbidities and Schizophrenia [J].
Buckley, Peter F. ;
Miller, Brian J. ;
Lehrer, Douglas S. ;
Castle, David J. .
SCHIZOPHRENIA BULLETIN, 2009, 35 (02) :383-402